Armistice Capital »

ViaSat shares owned by Armistice Capital

Quarter-by-quarter ownership of ViaSat (VSAT) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in ViaSat

Tip: Access up to 7 years of quarterly data

All positions including ViaSat held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ViaSat by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $290k 3.2k 89.81

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding ViaSat

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
American Century Companies
Carronade Capital Management
Citadel Advisors
Dimensional Fund Advisors
Disciplined Growth Investors
Geode Capital Management
OCO Capital Partners
Neuberger Berman Group
Invesco
T. Rowe Price Associates
Hanna Zanoni

View all funds holding ViaSat